Suppliers / Corden Pharma Boulder

Corden Pharma Boulder

United States Updated 9 July 2026

The public registers hold a second record for Corden Pharma Boulder. The fuller profile, with 17 active US DMFs and 3 valid CEPs, is at Corden Pharma. Figures on this page cover only this record.

Corden Pharma Boulder is an API manufacturer based in United States. It holds one active US drug master file and one valid CEP. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 14 November 2025 as NAI.

1
active US DMFs
1
valid CEPs
1
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 14 November 2025 NAI US FDA
  • 6 February 2019 VAI US FDA
  • 30 March 2018 NAI US FDA
  • 2 May 2016 VAI US FDA
  • 12 February 2016 NAI US FDA
  • 28 June 2013 VAI US FDA
  • 15 May 2013 VAI US FDA
  • 11 May 2012 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Boulder, United States 1710165

What they file, and where

Molecule Regulators Docs
Paclitaxel EDQM, US FDA 2

Also appears on these molecule pages

Paclitaxel API

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA None 1

Questions about Corden Pharma Boulder

Does Corden Pharma Boulder hold a US DMF or a CEP?
Corden Pharma Boulder holds 1 active US drug master file and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Corden Pharma Boulder FDA-registered?
One site operated by Corden Pharma Boulder carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Corden Pharma Boulder's last inspection go?
The most recent inspection on record closed on 14 November 2025 as NAI (No Action Indicated: nothing objectionable was found). 8 inspections are on file.
Where does Corden Pharma Boulder manufacture?
1 registered site is on record, in United States (Boulder). Every site is listed on this page with the register it came from.
What does Corden Pharma Boulder make?
1 molecule is on record against Corden Pharma Boulder, including Paclitaxel. Each links through to that molecule's full manufacturer list.
Which regulators recognise Corden Pharma Boulder's GMP?
Current GMP certificates are on record from US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Corden Pharma Boulder comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was NAI, on 14 November 2025.

Comparable suppliers

MSN Laboratories shares 1 molecule Apitoria Pharma shares 1 molecule Hetero shares 1 molecule ScinoPharm Taiwan shares 1 molecule Fresenius Kabi shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates